Seeking AlphaThu, 09 Apr 2026 05:56:11 GMTMesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&D Day TranscriptMESO+1.47%
Seeking AlphaWed, 08 Apr 2026 17:26:30 GMTWhy Mesoblast's Move Into DMD Warrants A Speculative Buy (Upgrade)MESO+1.47%
Seeking AlphaFri, 27 Feb 2026 07:27:52 GMTMesoblast Limited (MESO) Q2 2026 Earnings Call TranscriptMESO+1.47%